Your session is about to expire
← Back to Search
Lifestyle Intervention for Alzheimer's Prevention (POINTER Trial)
N/A
Waitlist Available
Led By Laura D Baker, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Capacity to complete physical exercise
Be older than 18 years old
Must not have
Use of psychoactive medications for exclusionary medical conditions
Serious conduction disorder, uncontrolled arrhythmia, or specific ECG findings
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if lifestyle changes can help protect memory and thinking in older adults.
Who is the study for?
This trial is for African American/Black, Native American, or Hispanic/Latinx individuals aged 60-79 with a low MIND diet score and suboptimal cardiovascular health. It's for those who are sedentary, have a family history of memory issues but no cognitive impairment themselves. Participants must live in the study area without extended travel plans and be willing to engage in lifestyle changes for at least two years.
What is being tested?
The POINTER study tests whether lifestyle interventions like physical activity, cognitive exercises, dietary changes, and social engagement can protect against memory loss in older adults at risk. Participants will be randomly assigned to either a self-guided or structured program based on successful Finnish models.
What are the potential side effects?
Since this trial involves lifestyle modifications rather than medications, side effects are not typical as with drug trials. However, participants may experience fatigue or muscle soreness from new exercise routines or digestive changes due to diet adjustments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am able to perform physical exercises.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am not taking any psychoactive drugs for certain health conditions.
Select...
I have a serious heart rhythm problem.
Select...
I am currently in physical therapy or cardiopulmonary rehab.
Select...
I do not have any major neurological conditions.
Select...
My condition meets the lung disease criteria.
Select...
I have not had hip, joint, or spinal surgery in the last 6 months.
Select...
I have had weight loss surgery that affects how my body absorbs food.
Select...
I have taken medication for memory problems or Alzheimer's disease.
Select...
I use insulin to manage my type 2 diabetes.
Select...
I have a serious heart condition.
Select...
I am either younger than 60 or older than 80 years old.
Select...
My kidneys are in the final stage of failure.
Select...
I have not had major depression in the last 6 months.
Select...
I am currently receiving hospice care.
Select...
I am currently taking corticosteroids every day.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Global cognitive function
Secondary study objectives
Clinical Dementia Rating-Sum of Boxes
Digital Clock Drawing Test (DCTClock)
Memory
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Structured Lifestyle InterventionExperimental Treatment1 Intervention
Lifestyle modification program that involves participants completing structured activities that target diet, physical exercise, and intellectual and social stimulation.
Group II: Self-Guided Lifestyle InterventionExperimental Treatment1 Intervention
Lifestyle modification program that is developed by the participant to meet his/her specific needs.
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,394 Previous Clinical Trials
2,458,036 Total Patients Enrolled
Alzheimer's AssociationOTHER
97 Previous Clinical Trials
40,639 Total Patients Enrolled
Laura D Baker, PhDPrincipal InvestigatorWake Forest University Health Sciences
4 Previous Clinical Trials
3,992 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not taking any psychoactive drugs for certain health conditions.I have a serious heart rhythm problem.I have not had a heart attack, major heart surgery, or blood clots in the past specified months.A close family member has had memory problems.I am between 70 and 79 years old.I am currently in physical therapy or cardiopulmonary rehab.I am able to perform physical exercises.I do not have any major neurological conditions.I have not had a stroke within the specified time frame.My condition meets the lung disease criteria.I have been treated for cancer within the last 2 years.I have not had hip, joint, or spinal surgery in the last 6 months.I am willing to follow a lifestyle intervention plan.I have had weight loss surgery that affects how my body absorbs food.I am male.I have high blood pressure, high cholesterol, or high blood sugar.I have taken medication for memory problems or Alzheimer's disease.I use insulin to manage my type 2 diabetes.I have a serious heart condition.I am either younger than 60 or older than 80 years old.My kidneys are in the final stage of failure.I have not had major depression in the last 6 months.I am currently receiving hospice care.I am currently taking corticosteroids every day.The study is specifically looking for participants who are African American/Black, Native American, or Hispanic/Latinx.You have a high risk of cognitive decline based on a specific scoring system.You have to have good memory and thinking skills, and not have signs of dementia.
Research Study Groups:
This trial has the following groups:- Group 1: Structured Lifestyle Intervention
- Group 2: Self-Guided Lifestyle Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Alzheimer's Disease Patient Testimony for trial: Trial Name: NCT03688126 — N/A
Share this study with friends
Copy Link
Messenger